Skip to content

AI in Drug Discovery & Development

By Sara Mallatt, Director of Healthcare Research and Sean Carmichael

Hype, Reality, and What Comes Next

IndustryLife Sciences & Healthcare

AI has emerged as a powerful potential solution that could revolutionize how drugs are discovered, developed, and brought to patients. AlphaSense recently hosted an expert call with Dr. Paul Agapow, Former Director of Data Science at GSK, to discuss how AI is making inroads in this area.

Drawing from the call with Dr. Agapow, the latest data, and additional expert insights, this report covers how AI is performing against high expectations, what’s working, and what's not. This report also dissects the competitive arena, covering both today’s key players and the mergers, acquisitions, and collaborations that are defining the future.

About the Authors

  • Sara Mallatt, Director of Healthcare Research

    Sara has more than 18 years of experience generating sell-side research content across a variety of industries. Prior to joining AlphaSense, Sara held leadership positions at OTR Global, a leading channel research firm, most recently as Director of Healthcare Research. Sara holds a bachelor’s degree in journalism and a master’s in industrial engineering. She works from her home in Missoula, Montana.

  • Sean Carmichael

    Sean is a Business & Finance Editor at AlphaSense, specializing in sector-specific content production. Previously, he spent nearly a decade in various roles across financial services, where he was responsible for equity research and content generation geared toward institutional investors.

Explore more

All articles

AI in Drug Development 2026: From Experimentation to Execution

Learn how AI is reshaping drug development in real time, turning AI execution into a key competitive differentiator.
Report
Presentation slide titled "AI in Drug Development 2026: From Experimentation to Execution" by Sara Mallatt and Sean Carmichael, with line art of laboratory equipment.

AlphaSense a Leader in the 2026 Gartner® Magic Quadrant™ for Competitive & Market Intelligence Platforms

AlphaSense was named a Leader in the inaugural Gartner® Magic Quadrant™ for Competitive and Market Intelligence (CMI) Platforms, positioned highest on Ability to Execute and furthest on Completeness of Vision. We believe this validates AlphaSense's strategic direction and commitment to innovation within the competitive and market intelligence space.
Report
Gartner Magic Quadrant chart from April 2026, positioning AlphaSense as a leader in completeness of vision and ability to execute.

Top AI Use Cases for Corporate Development

In this report, learn how the most successful corporate development teams are using platforms like AlphaSense to better source ideas, build conviction, and generate defensible recommendations.
Report
Blue blueprint-style illustration: 'Top AI Use Cases for Corporate Development' by Sean Carmichael. Features a briefcase, currency symbols, and abstract designs.

Transform intelligence
into advantage

Develop bold strategies, seize opportunities,
and lead with clarity and confidence.